Citation Impact
Citing Papers
A review on medicinal plants with antidiabetic activity
2014
Extracting pharmaceuticals from water using metal–organic frameworks
2023 StandoutNobel
Functional Cross-talk between β-Catenin and NFκB Signaling Pathways in Colonic Crypts of Mice in Response to Progastrin
2009
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Profiling Induction of Cytochrome P450 Enzyme Activity by Statins Using a New Liquid Chromatography-Tandem Mass Spectrometry Cocktail Assay in Human Hepatocytes
2010
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Pomegranate and its Many Functional Components as Related to Human Health: A Review
2010 Standout
Cytochrome P450: taming a wild type enzyme
2011 StandoutNobel
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Oral Anticoagulant Therapy
2012 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China
2010
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
Discovery of a Novel Allelic Variant of CYP2C8, CYP2C8*11, in Asian Populations and Its Clinical Effect on the Rosiglitazone Disposition In Vivo
2011
Ellagitannin Consumption Improves Strength Recovery 2-3 d after Eccentric Exercise
2010 Standout
Fruit juice inhibition of uptake transport: a new type of food–drug interaction
2010
Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China
2008
Hydrophilic interaction chromatography
2006 Standout
Inflammation and Colon Cancer
2010 Standout
STEREOSELECTIVE METABOLISM OF LANSOPRAZOLE BY HUMAN LIVER CYTOCHROME P450 ENZYMES
2003
The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance
2008
CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy ofHelicobacter pyloriinfection
2009
Genetic polymorphism of hepatocyte nuclear factor‐4α influences human cytochrome P450 2D6 activity†
2008
Immunity, Inflammation, and Cancer
2010 Standout
CYP2C19 Polymorphism and Proton Pump Inhibitors
2004
Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: functional crosstalk between the Wnt-5A and NF-κB signaling pathways
2010
Can NF-κB be a target for novel and efficient anti-cancer agents?
2006
Engineering and assaying of cytochrome P450 biocatalysts
2008
Development and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometric method for the analysis of paroxetine in human plasma
2003
Non‐natural Olefin Cyclopropanation Catalyzed by Diverse Cytochrome P450s and Other Hemoproteins
2014 StandoutNobel
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Pomegranate peel and peel extracts: Chemistry and food features
2014 Standout
CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese
2006
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Fingerprinting food: current technologies for the detection of food adulteration and contamination
2012 Standout
Chemistry, Pharmacology and Health Benefits of Anthocyanins
2016
Activation of H2O2 by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation
2012 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Pinitol targets nuclear factor-κB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis
2008
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Therapeutic applications of pomegranate (Punica granatum L.): a review.
2008 Standout
Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health
2011 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Role of Polyphenols in Abiotic Stress Response: The Influence of Molecular Structure
2021 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Cytochrome P450-Mediated Drug Interactions
2000
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Asymmetric Counteranion‐Directed Iron Catalysis: A Highly Enantioselective Sulfoxidation
2012 StandoutNobel
Applications of Catalytic Asymmetric Sulfide Oxidations to the Syntheses of Biologically Active Sulfoxides
2005
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
DissimilarIn VitroandIn VivoEffects of Ellagic Acid and Its Microbiota-Derived Metabolites, Urolithins, on the Cytochrome P450 1A1
2009
Current Understanding of Pathogenesis and Treatment of TMJ Osteoarthritis
2015 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Fluorine in health care: Organofluorine containing blockbuster drugs
2010 Standout
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
The role of medicinal plants in the treatment of diabetes: a systematic review
2016 Standout
Preparation and Evaluation of Potent Pentafluorosulfanyl‐Substituted Anti‐Tuberculosis Compounds
2017
Safety and Antioxidant Activity of a Pomegranate Ellagitannin-Enriched Polyphenol Dietary Supplement in Overweight Individuals with Increased Waist Size
2007
Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions
2004
CLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics
2005
Works of In‐June Cha being referenced
Pinitol from Soybeans Reduces Postprandial Blood Glucose in Patients with Type 2 Diabetes Mellitus
2006
High‐throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry
2005
INHIBITORY EFFECTS OF FRUIT JUICES ON CYP3A ACTIVITY
2006
Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma
1998
Effect of Rifampin on the Plasma Concentration and the Clinical Effect of Haloperidol Concomitantly Administered to Schizophrenic Patients
1996
Diclofenac attenuates Wnt/β‐catenin signaling in colon cancer cells by activation of NF‐κB
2005
LANSOPRAZOLE ENANTIOMER ACTIVATES HUMAN LIVER MICROSOMAL CYP2C9 CATALYTIC ACTIVITY IN A STEREOSPECIFIC AND SUBSTRATE-SPECIFIC MANNER
2004
Genetic Polymorphism of CYP2C9 in a Vietnamese Kinh Population
2005
Frequency of cytochrome P450 2C9 mutant alleles in a Korean population
2001
Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population
2009
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the genetic polymorphism
2005
Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19
2002